コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 activating phosphorylation by Mst1, a serine/threonine kinase.
2 epends on the RTKs activating the AKT serine/threonine kinase.
3 segment conformation of tyrosine and serine/threonine kinases.
4 the protein kinase D (PKD) family of serine/threonine kinases.
5 rylation at Ser133 by various protein serine/threonine kinases.
6 phytochromes are autophosphorylating serine/threonine kinases.
7 amino acid sequences of human protein-serine/threonine kinases.
8 clins associate with cyclin-dependent serine/threonine kinase 1 (CDK1) to generate the M phase-promot
11 uired caspase-8, receptor-interacting serine/threonine kinase 1 (RIPK1), and Fas-associated death dom
12 -activated protein kinase interacting serine/threonine kinase 1 activation significantly suppresses T
14 lower levels of receptor-interacting serine-threonine kinase 1 and shorter survival times of patient
15 ivated protein kinase and phospho-AKT serine/threonine kinase 1 signaling pathways, as well as increa
16 Ripk1 (receptor (TNFRSF)-interacting serine-threonine kinase 1) expression, and miR-155-5p inhibitio
18 TBK1 (TANK-Binding Kinase 1)-AKT (AKT serine/threonine kinase 1)-IRF3 (interferon regulatory factor 3
19 ed levels of the receptor-interacting serine-threonine kinase 1, a mediator of necroptosis, in CRC ce
20 fibroblasts from receptor interacting serine/threonine kinase 1-knockout mice or their WT littermates
21 te-oriented kinase (LOK), also called serine threonine kinase 10 (STK10), is synthesized mainly in ly
24 Liver kinase B1 (LKB1), also known as serine/threonine kinase 11 (STK11) is the major energy sensor f
26 (LKB1) tumor suppressor gene, Stk11 (serine threonine kinase 11), in the fetal Mullerian duct mesenc
27 Liver kinase B1 (LKB1, also known as serine/threonine kinase 11, STK11) is a tumor suppressor mutate
29 sregulation of microtubule-associated serine/threonine kinase 2 and protein-o-mannose kinase SGK196 i
30 mediated through receptor-interacting serine/threonine kinase 2, and the transcriptional regulator CC
32 and in vivo by microtubule-associated serine/threonine kinase 3 (MAST3 kinase), an enzyme of previous
33 cally depends on receptor-interacting serine-threonine kinase 3 (RIPK3) and mixed lineage kinase doma
37 lin-1) by RIPK4 (receptor-interacting serine-threonine kinase 4) during epidermal differentiation.
39 KD2) is a member of the PKD family of serine/threonine kinases, a subfamily of the CAMK super-family.
40 ted that IkappaB kinase beta is a key serine/threonine kinase activated by autophagy stimuli and that
41 ng protein kinase (HIPK) 2, a nuclear serine/threonine kinase, activates CREB through Ser271 phosphor
42 cificity kinase and both tyrosine and serine/threonine kinase activities are required for its functio
44 terms protein kinase activity/protein serine threonine kinase activity, response to heat and reactive
47 mice lacking specific isoforms of the serine/threonine kinase AKT and bone marrow chimeras, we found
48 hosphatidylinositol-3-OH kinase), the serine-threonine kinase Akt and the metabolic checkpoint kinase
49 ied a signaling pathway-involving the serine-threonine kinase AKT and the transcription factor XBP1s,
55 In response to growth factors, the serine/threonine kinase AKT phosphorylates Thr(24) and Ser(256)
59 ckpoint kinase complex mTORC2 and the serine-threonine kinase Akt, and loss of this activity restores
60 depends on the activation of PI3K and serine-threonine kinase Akt, and protein synthesis relies on th
64 activation-induced phosphorylation of serine-threonine kinases Akt and mechanistic target of rapamyci
66 phosphoinositide 3-kinase (PI3K)/Akt serine/threonine kinase (Akt) and mitogen-activated protein kin
68 has led to the identification of the serine/threonine kinase ALK2 as a potential target for therapeu
70 se (NLK) is an evolutionary conserved serine/threonine kinase and a negative regulator of the Wnt sig
72 ion of general control nonrepressed 2 serine/threonine kinase and increased expression of mammalian t
73 ion of general control nonrepressed 2 serine/threonine kinase and mammalian target of rapamycin (both
74 focus on coordination of postsynaptic serine/threonine kinase and phosphatase signaling by scaffold p
75 downstream signaling through the ERK serine/threonine kinase and the Fos transcription factor, there
77 ATIONALE: LKB1 (liver kinase B1) is a serine/threonine kinase and tumor suppressor, which regulates t
79 y ataxia telangiectasia mutated (ATM) serine/threonine kinase, and this phosphorylation is required f
80 expression of the oncogenic PIM1/2/3 serine/threonine kinases, and as PIMs modulate transcriptional
81 We show that the apically localized serine/threonine kinase aPKC directly phosphorylates an N-termi
82 ify CDK5, a predominantly cytoplasmic serine/threonine kinase, as an important regulator of DLC1 func
83 ous to penicillin-binding protein and serine/threonine kinase associated (PASTA) domains, and binds f
84 llular penicillin-binding-protein and serine/threonine kinase-associated (PASTA) domains which bind m
85 terial Penicillin-binding-protein And Serine/Threonine kinase-Associated (PASTA) kinases is of partic
87 1 is phosphorylated by the DNA damage serine/threonine kinase ATM, resulting in increased levels of F
88 led to reduced phosphorylation of the serine/threonine kinases ATM and Chk2 and of histone H2AX after
89 rations in FA-complex genes or in ATM serine/threonine kinase (ATM) exhibited significantly longer tr
90 ment of ataxia-telangiectasia mutated serine/threonine kinase (ATM) to the damaged site, where it pla
91 ion of Gene 33 triggers DDR in an ATM serine/threonine kinase (ATM)-dependent fashion and through pat
94 ement within the RAS/ERK pathway, the serine/threonine kinase BRAF plays a key role in development an
96 protein kinase B-Raf proto-oncogene, serine/threonine kinase (BRAF) is an oncogenic driver and thera
97 henotype (CIMP), B-Raf proto-oncogene serine/threonine kinase (BRAF) mutation, and Kirsten rat sarcom
98 ability, and the B-Raf protooncogene, serine/threonine kinase (BRAF), mutation) in the Nurses' Health
99 as PLK1 (Polo-like kinase 1), C-MYC, serine-threonine kinase BUB1B and regulates their expression.
101 ivity is controlled by the Pkn8/Pkn14 serine/threonine kinase cascade, which phosphorylates MrpC on t
102 Here we report that the conserved serine/threonine kinase, casein kinase II (CK2), promotes miRIS
104 e 7-amino acid truncation in NUAK2, a serine/threonine kinase, completely abrogated its catalytic act
106 tion of their primary sequences, many serine-threonine kinases display a significant preference for s
108 ate 1970s, is composed of at least 10 serine/threonine kinases, divided into three groups based on th
109 apoptotic gene FASTKD2 (fas-activated serine/threonine kinase domains 2; rs7594645-G) with better mem
110 tivated kinases (PAK) are a family of serine/threonine kinases downstream of multiple critical tumori
112 nase 1 (DCLK1), a microtubule binding serine threonine kinase, emerged as a promising target due to i
113 show that the kinase activity of the serine/threonine kinase encoded by TAOK2 is required for spine
114 The Escherichia coli eukaryote-like serine/threonine kinase, encoded by yeaG, is expressed in respo
115 , we find that phosphorylation of the serine/threonine kinase ERK (pERK) preferentially occurs in end
116 well appreciated that eukaryotic-like serine/threonine kinases (eSTKs) control essential processes in
118 cting NEK2, a member of the NIMA-like serine-threonine kinase family, in a patient with congenital he
120 tein kinase C constitutes a family of serine-threonine kinases found in all eukaryotes and implicated
123 in vitro functional studies, a novel serine/threonine kinase gene, unc-51-like kinase 4 (ULK4), as a
127 synthase kinase-3 beta (GSK-3beta), a serine/threonine kinase, has been identified as a potential the
131 ibrain (Mnb; also known as Dyrk1A), a serine/threonine kinase implicated in autism spectrum disorder
133 kinase kinase kinase 4 (MAP4K4) is a serine/threonine kinase implicated in the regulation of many bi
134 Protein kinase C (PKC) is a family of serine/threonine kinases implicated in a variety of physiologic
135 e c-Jun N-terminal kinases (JNKs) are serine/threonine kinases implicated in the pathogenesis of vari
136 PKD) is a family of stress-responsive serine/threonine kinases implicated in the regulation of divers
140 , we identified PIM1, a non-essential serine-threonine kinase, in a synthetic lethal interaction with
143 ul stimulus or treatment with the AKT Serine/Threonine kinase inhibitor SH-6 restored splicing factor
144 alciparum exports a family of 18 FIKK serine/threonine kinases into the host cell, suggesting that ph
146 rylation-regulated kinase DYRK1A is a serine/threonine kinase involved in neuronal differentiation an
147 e-3 (GSK3) are ubiquitously expressed serine-threonine kinases involved in a plethora of functions ra
149 ously determined that a transmembrane serine/threonine kinase (IreK) and its cognate phosphatase (Ire
150 l-originated protein kinase (TOPK), a serine-threonine kinase is activated by SUV irradiation and inv
153 (CK1alpha), a ubiquitously expressed serine/threonine kinase, is a key negative regulator of oncogen
156 at casein kinase 1 alpha (Csnk1a1), a serine-threonine kinase, is essential for AML cell survival in
157 se (NLK), an evolutionarily conserved serine/threonine kinase, is highly expressed in the brain, but
160 ber of the polo-like kinase family of serine-threonine kinases, is a master regulator of centriole du
162 optosis signal-regulating kinase 1, a serine/threonine kinase, leads to improvement in inflammation a
163 kinase (called microtubule-associated serine/threonine kinase like [Mastl] in mammals) is essential f
170 -activated protein kinase-interacting serine-threonine kinases MAP kinase-interacting kinase 1 (Mnk1/
175 nous PTEN-induced kinase 1 (PINK1), a serine/threonine kinase mutated in a recessive forms of Parkins
176 ntify protein kinase C (PKC) gamma, a serine/threonine kinase mutated in the neurodegenerative diseas
179 reen, we identified a mitotic-related serine/threonine kinase, NEK6, as a mediator of androgen-indepe
180 canonical NF-kappaB signaling via the serine/threonine kinase NIK (NF-kappaB-inducing kinase) remains
182 protein kinase (Drak), a cytoplasmic serine/threonine kinase orthologous to the human kinase STK17A,
183 protein kinase (Drak), a cytoplasmic serine/threonine kinase orthologous to the human kinase STK17A.
184 of these binding partners include the serine/threonine kinases, p21-activated kinase 1 (PAK1), apopto
185 determined that d-flow activated the serine/threonine kinase p90RSK, which subsequently phosphorylat
190 The hypoxia-inducible, pro-oncogenic, serine-threonine kinase PIM1 (Proviral Integration site for Mol
193 We found that RhoA activated the serine-threonine kinases PKN1 and PKN2 that bind and phosphoryl
202 coupled receptor kinase 5 (GRK5) is a serine/threonine kinase previously shown to mediate polymicrobi
203 RIPK1 and RIPK3, a pair of homologous serine/threonine kinases previously implicated in the regulatio
204 echanistic target of rapamycin (mTOR) serine/threonine kinase promotes myelination, but factors that
205 dually suppressed RAF1 proto-oncogene serine/threonine kinase (RAF1)/ERK signaling through the intera
207 ike kinase 1 (ALK1) is an endothelial serine-threonine kinase receptor for bone morphogenetic protein
210 ng protein kinase (Hipk), a conserved serine-threonine kinase, regulates numerous factors during tiss
211 a B (AURKB) and Aurora C (AURKC), are serine/threonine kinases required for the control of mitosis (A
212 c approach identified PKCtheta as the serine/threonine kinase responsible for alphaPIX serine phospho
213 siRNA-mediated inhibition of various serine/threonine kinases revealed ERK1/2 as a positive regulato
214 RNA virus, triggers activation of the serine-threonine kinases RIP1 and RIP3, which damages mitochond
218 , OGT-mediated O-GlcNAcylation of the serine-threonine kinase RIPK3 on threonine 467 (T467) prevented
219 e translocation and activation of the serine/threonine kinase ROCK1, a downstream target of the RhoA
220 ORC1 activation deploys the ribosomal serine/threonine kinase S6K1 and Polycomb proteins at genomic r
222 n protein folding, protein synthesis, serine/threonine kinase signalling, glycolysis and gluconeogene
223 on-like (drl-1) gene, which encodes a serine/threonine kinase similar to the mammalian MEKK3 kinase.
224 d by mass spectrometry identified the serine-threonine kinase SPEG as the only novel binding partner
225 d by mass spectrometry identified the serine-threonine kinase SPEG as the only novel binding partner
229 kers, one (rs10937625) located in the serine/threonine kinase STK32B and one (rs17590046) in the tran
231 o interferes with the activity of the serine/threonine kinase StkP, the central regulator of pneumoco
233 Trans-membrane signaling involving a serine/threonine kinase (Stt7 in Chlamydomonas reinhardtii) dir
234 dentifying degrader hits based on the serine/threonine kinase TANK-binding kinase 1 (TBK1) and have g
236 enerated Taok3(-/-) mice, lacking the serine/threonine kinase Taok3, and found cell-intrinsic defects
241 ontaining protein kinase 2 (ROCK2), a serine-threonine kinase that can be therapeutically targeted by
242 istic target of rapamycin (mTOR) is a serine-threonine kinase that coordinates nutrient and growth fa
243 apamycin (MTOR) is a highly conserved serine/threonine kinase that critically regulates cell growth,
244 racting protein kinase 1 (RIPK1) is a serine/threonine kinase that dictates whether cells survive or
245 et of rapamycin (mTOR) is an atypical serine/threonine kinase that exerts its main cellular functions
246 et of rapamycin (mTOR) is a conserved serine/threonine kinase that forms two complexes, mTORC1 and mT
247 protein kinase 2 (HIPK2) is a nuclear serine/threonine kinase that functions in development and tumor
251 e (AMPK) is an evolutionary conserved serine/threonine kinase that integrates cellular energy status
252 eptor-interacting protein (RIP1) is a serine/threonine kinase that integrates inflammatory and necrop
254 led that Polo-like kinase 1 (PLK1), a serine/threonine kinase that is essential for cell cycle progre
255 t cyclin-dependent kinase 5 (Cdk5), a serine-threonine kinase that is highly active in postmitotic ne
256 ublecortin-like kinase 1 (DCLK1) is a serine/threonine kinase that is overexpressed in gastrointestin
257 is PIM2, which encodes a prosurvival serine-threonine kinase that phosphorylates and inhibits the pr
259 ns was GSG2 (also known as Haspin), a serine/threonine kinase that phosphorylates histone H3 at Thr-3
260 1-like kinase 1 (ULK1) is a conserved serine-threonine kinase that plays a central role in the initia
261 is a highly conserved and pleiotropic serine/threonine kinase that promotes many prosurvival and proi
262 re we identify Stk2, a staphylococcal serine/threonine kinase that provides efficient immunity agains
263 alian target of rapamycin (mTOR) is a serine/threonine kinase that regulates a diverse array of cellu
264 e A (PKA) is a ubiquitously expressed serine/threonine kinase that regulates a variety of cellular fu
265 Tumor progression locus 2 (Tpl2) is a serine-threonine kinase that regulates Th1 differentiation, sec
266 ed kinases (PAKs) are a family of six serine/threonine kinases that act as key effectors of RHO famil
267 OCK1 and ROCK2) are highly homologous serine/threonine kinases that act on substrates associated with
269 are a family of constitutively active serine/threonine kinases that are partially redundant and regul
270 LegK1-4 proteins are eukaryotic-like serine/threonine kinases that are translocated by the Dot/Icm t
271 CK) is a member of a diverse group of serine/threonine kinases that feature cytoskeletal association.
273 mologous and functionally overlapping serine/threonine kinases that phosphorylate multiple protein su
274 ceptor-associated kinases (IRAKs) are serine/threonine kinases that play critical roles in initiating
275 y of abundant, ubiquitously expressed serine/threonine kinases that regulate multiple cellular proces
276 ho kinases, or ROCKs, are a family of serine-threonine kinases that serve as key downstream effectors
277 e examine the STE20 family of protein serine-threonine kinases to investigate basic mechanisms of sub
282 through binding and activation of the serine/threonine kinase type II TGF-beta receptor (TbetaRII), w
283 of the essential autophagy initiator serine-threonine kinase ULK1, and increased in the activity upo
284 n of the MTOR complex 1 (RAPTOR), the serine/threonine kinase V-Akt murine thymoma viral oncogene hom
286 pe II (TbetaRII) and type I (TbetaRI) serine/threonine kinases, whereby Smad2 and Smad3 are phosphory
287 kinase 5 (Cdk5) is a proline-directed serine/threonine kinase which is mostly active in the nervous s
289 interacts with calmodulin-associated serine/threonine kinase, which is implicated in X-linked mental
290 PAK4 is a member of the PAK family of serine/threonine kinases, which act as effectors for several sm
292 se II (CaMKII) is a calcium-regulated serine threonine kinase whose functions include regulation of s
294 protein kinase (AMPK) is a conserved serine/threonine kinase with a critical function in the regulat
295 coupled receptor kinase 2 (GRK2) is a serine/threonine kinase with an important function in the desen
296 racting protein kinase 3 (RIPK3) is a serine/threonine kinase with essential function in necroptosis.
297 Casein kinase 1 alpha (CK1alpha) is a serine/threonine kinase with numerous functions, including regu
298 polo-like kinases (PLK), a family of serine/threonine kinases with well-known roles in cell cycle re